Skip to main content

Finasteride Fertility Effects and Pregnancy Safety

How does finasteride affect fertility, semen, and pregnancy safety?

If you're taking finasteride in your twenties or thirties, you're suppressing the same hormone that runs the glands making most of your seminal fluid. That overlap is why the fertility question is real, and why the honest answer splits in two: what the drug does to your semen, and what it could do to a pregnancy. Those are separate questions with separate answers, and the second one turns out to be about how tablets get handled far more than it's about you.

1 mg DHT suppression: 65% to 70% 1 mg sperm concentration over 48 weeks: no meaningful change 5 mg ejaculate volume: down 20% to 30% Semen washout: about 3 months Drug per ejaculate: 7 to 8 nanograms
The Throughline

At the 1 mg dose used for pattern hair loss, a 48 week placebo controlled trial found no clinically meaningful change in sperm concentration, motility, or morphology, and the pregnancy risk that actually matters comes from a pregnant woman handling a broken tablet rather than from exposure through semen.

What happens to sperm count, motility, and ejaculate volume while a man is taking finasteride?

One trial does most of the heavy lifting here: 48 weeks, healthy men aged nineteen to forty one, 1 mg a day, repeated semen samples. The group averages barely moved. What an average hides is the tail of the distribution, and you're not an average, you're one man with one baseline.

  • Concentration, motility, morphology: No clinically meaningful change against placebo across 48 weeks.
  • Ejaculate volume: Down about 11% on drug against about 8% on placebo, not significant.
  • The 5 mg dose: Volume reductions commonly land in the 20% to 30% range.
  • The tail: A clinic series of twenty seven men showed roughly elevenfold count recovery after stopping.
Technical Verdict

Over 48 weeks of 1 mg daily, sperm concentration, total motility, and normal morphology showed no clinically meaningful change against placebo, and the average man on that dose stays inside every WHO sixth edition reference limit, including 16 million sperm per mL and 42 percent total motility.

Why does blocking DHT reduce the volume of the ejaculate?

Most men assume the ejaculate comes from the testes. It barely does, and almost all of that fluid is made by two glands that run on DHT, so suppressing DHT shrinks the delivery vehicle without touching the cargo.

Seminal vesicles, roughly 65% to 70% of the volume: The largest single source, and squarely androgen dependent.
Rich in type II 5 alpha reductase, so they convert testosterone into DHT locally.
Prostate, roughly 20% to 30%: Same androgen drive, and the easiest one to measure from outside.
At 5 mg, prostate volume falls about 20% within three months and prostate specific antigen roughly halves.
Testes and epididymis, about 2% to 5%: The sperm themselves, and a rounding error by volume.
Run by high intratesticular testosterone plus follicle stimulating hormone, neither of which finasteride removes.
Established Fact

The seminal vesicles and prostate together supply roughly 85 to 95 percent of the ejaculate and both depend on DHT, while the testes and epididymis contribute only about 2 to 5 percent, which is why finasteride can cut volume without changing sperm production.

Are finasteride's effects on semen reversible after stopping the drug?

Two clocks start running when you take the last tablet, and mixing them up is where most of the bad advice comes from. The drug is gone in hours, but semen lags by months, because the cells in today's sample were built weeks ago under the drug.

  1. Hours: Plasma half life runs about five to six hours in men aged eighteen to sixty.
  2. Two weeks: Suppressed DHT climbs back toward baseline, though the semen hasn't changed yet.
  3. About sixty four days: A full round of sperm production plus epididymal transit finally clears.
  4. Three months: The earliest analysis worth interpreting, and where real recovery usually shows up.
The Long View

Because a sperm cell takes about sixty four days on average to travel from precursor to ejaculate, a semen analysis run at roughly three months after the last tablet is the earliest one worth interpreting, and the most cited clinic series recorded an approximately elevenfold rise in count after withdrawal with no man ending lower than he started.

How much does the dose matter, the 1 mg hair loss tablet compared with the 5 mg prostate tablet?

The 5 mg tablet carries five times the milligrams, so you'd expect five times the hormonal hit. You don't get it. The suppression curve flattens well below 5 mg, so where the two doses really part company isn't DHT at all, it's the accessory gland effect and the men who take each one.

Criteria 1 mg (hair loss) 5 mg (prostate)
Serum DHT suppression 65% to 70% About 70%
Ejaculate volume change About 11%, not significant 20% to 30%
Volume recovery after stopping Not a meaningful effect at this dose Averaged 84 weeks
Who takes it Men in their twenties and thirties Older men with prostate enlargement
Decision Point

One milligram daily already suppresses serum dihydrotestosterone by roughly 65 to 70 percent against roughly 70 percent at five milligrams, so the hair loss dose isn't hormonally trivial, and splitting a 5 mg tablet to reach it destroys the film coating that keeps loose drug off anyone's hands.

Can finasteride actually cause infertility, or does it only shift numbers on a lab report?

Both answers you've read are true, just about different men. For most, the drug moves a number in a lab column and changes nothing about how long conception takes, but the men who get hurt by it are almost always the ones already carrying something else.

Baseline count well above the reference limit: A volume driven drop of 20% to 30% still leaves you an enormous buffer.
Baseline near the lower limit, 16 to 18 million per mL: You've got almost no room to absorb a reduction, so get an analysis before you assume you're fine.
A varicocele, prior chemotherapy, thyroid or prolactin trouble, obesity, or heavy heat exposure: Finasteride is the one removable variable in the stack, and removing it is cheap.
Severe oligospermia or azoospermia while on the drug: Stop for three months and run the full male infertility workup rather than pinning it on the tablet.
Where It Goes Wrong

Finasteride's fertility risk is concentrated in a minority phenotype, with published cases of men on 1 mg daily whose counts sat in the severely oligospermic range with no other identified cause and rebounded roughly tenfold after stopping, while azoospermia is very rare and should always prompt a search for another explanation.

How long before trying to conceive should a man stop taking finasteride?

Three months is the number, and it comes from how long sperm take to build rather than from a trial. Stopping two weeks out clears the drug from your blood and leaves an entire pipeline of already made cells behind, which is why short washouts feel reassuring and tell you nothing. The bigger question is whether you need a washout at all, and most men don't.

  1. Get the baseline analysis first: Stopping without one destroys your ability to know whether anything changed.
  2. Decide whether a stop is warranted: Any abnormal parameter, twelve months of trying, six months if she's thirty five or older, or a known risk factor.
  3. Stop for about three months: Long enough for one full cycle of production to clear the drug's influence.
  4. Repeat and compare: Before and after is the only version of this that produces usable information.
  5. Plan the restart: Resuming once the pregnancy is confirmed is common, and topical minoxidil bridges the gap.
How Pros Do It

The standard washout is about three months, matched to the roughly sixty four day cycle of sperm production, and it's worth doing only with a baseline semen analysis taken before the stop and a repeat taken at the three month mark, since stopping without a baseline leaves nothing to compare.

Is a pregnant partner at risk from the semen of a man taking finasteride?

This is the one question where the arithmetic genuinely settles it. The drug does show up in semen, but at a few nanograms per ejaculate, hundreds of times below a dose that did nothing at all to circulating DHT in men. Walking through those numbers beats being told not to worry.

  • Semen concentration at 1 mg: Highest measured at about 1.5 nanograms per millilitre.
  • Semen concentration at 5 mg: Highest measured at about 10.5 nanograms per millilitre.
  • Exposure at 1 mg: 650 fold below the 5 microgram no effect dose, assuming complete absorption.
  • Reported human cases through semen: None established, and no change to prenatal management.
Safety Note

Even assuming a full ejaculate is completely absorbed, a partner's exposure through semen at the 1 mg dose sits 650 fold below the 5 microgram dose that produced no effect on circulating DHT in men, and no birth defect has been established as arising from paternal exposure by that route.

Why must pregnant women avoid handling broken or crushed finasteride tablets?

This one isn't about the woman's own health, and it isn't theoretical. Between roughly the eighth and fourteenth week of gestation the male external genitalia form under DHT rather than testosterone, and a 5 alpha reductase inhibitor crossing the placenta interferes with exactly that step. The film coating is the entire reason ordinary handling is safe.

Intact, film coated tablet: No exposure risk. Picking one up, refilling an organizer, or handing one to a partner is fine.
Broken, crushed, split, or chewed tablet: The barrier is gone and loose powder transfers to fingertips, so a pregnant woman must not touch it.
A spilled or damaged tablet in the house: Clear it with a paper towel rather than bare hands, and keep tablets in their original closed container.
Contact that has already happened: Wash with soap and water and mention it at the next prenatal visit. No emergency treatment exists or is warranted.
Regulatory Reality

Finasteride carried a pregnancy category X classification and an absolute contraindication in women who are or may become pregnant because animal work produced hypospadias in male offspring at maternal doses from roughly human therapeutic exposure upward, and intact film coated tablets pose no exposure risk while broken or crushed ones do.

What do sperm DNA fragmentation and other advanced tests show beyond a standard semen analysis?

A standard semen analysis counts cells, watches them swim, and grades their shape. It says nothing about whether the genetic material inside them is intact, which is the gap fragmentation testing fills and also the place where the finasteride evidence gets genuinely thin.

  • What it measures: The share of sperm carrying single or double strand DNA breaks.
  • The threshold: A fragmentation index above roughly 30 percent is generally read as unfavourable.
  • Finasteride evidence: Small studies split both ways, with no consensus and no shared assay.
  • When to order it: Recurrent pregnancy loss, failed assisted cycles, or unexplained infertility.
Expert Note

Sperm DNA fragmentation testing is indicated for recurrent pregnancy loss, repeated failure of assisted reproduction, or unexplained infertility with a normal conventional analysis, and taking finasteride is not on its own a reason to order it, since the studies on the drug and fragmentation contradict each other.

What hair loss treatment options exist for a man who is actively trying to conceive?

You don't have to choose between a family and your hairline. There's a full shelf of options with no systemic hormone exposure at all, and the only genuinely tricky one is the version of finasteride that sounds safest.

No systemic drug exposure: Low level laser therapy devices, microneedling, platelet rich plasma, and hair transplantation.
Transplanted follicles are genetically resistant to DHT, so the result holds regardless of what you do about medication afterwards.
Negligible systemic exposure: Topical minoxidil, with ketoconazole shampoo as a mild adjunct.
Minoxidil works on blood flow and the follicle rather than on hormones, so it runs straight through a conception attempt and a pregnancy.
Reduced but real systemic exposure: Topical finasteride.
Serum DHT suppression is measurable rather than absent, and the trials measured hormone levels, not fertility outcomes.
Full systemic exposure: The oral tablet, paused or continued.
Pausing gives back roughly the accumulated benefit over about twelve months, and most couples conceive inside that window.
In Practice

Topical minoxidil, low level laser therapy, microneedling, platelet rich plasma, and hair transplantation all avoid systemic DHT suppression and can be used continuously while trying to conceive, while pausing the oral tablet gives back roughly the accumulated benefit over about twelve months.

Daniel Zengel
Written by Daniel Zengel
Medical Writer
Daniel Zengel is the principal owner of H-SHOT and a medical writer covering platelet-rich plasma and hair restoration. He draws on more than a decade in pharmaceutical and medical device roles, with a focus on regenerative medicine and the device standards and provider training that make PRP results consistent from clinic to clinic.